An expert consensus panel reviewed treatment manuals for cognitive behavioral therapies for nightmares (CBT-N) tested in randomized clinical trials with adults. The panel developed guidelines for standardized implementation and terminology of CBT-N, addressing patient symptom presentations appropriate for treatment and components such as session length, relaxation training, stimulus control, sleep efficiency training, sleep hygiene, nightmare exposure, nightmare rescripting, and imagery rehearsal of rescripted dreams. The recommendations aim to clarify confusion caused by unstandardized nomenclature and implementation nuances, and are intended to be revised as new research evidence emerges.
Among 54 military veterans with posttraumatic stress disorder (PTSD) and recurrent nightmares, over half reported experiencing lucid dreaming—awareness during a dream that one is dreaming. Nearly all of those individuals specifically reported lucidity in nightmares. The lucid nightmare profile featured high awareness of dreaming but low control over dream content. Veterans described feeling stuck and anxious, and they tried unsuccessfully to awaken from these lucid nightmares. The findings suggest that lucid nightmares occur commonly in veterans with PTSD, with a profile similar to that previously reported for lucid dreaming experiences generally in this group.
Nightmares that persist after trauma often require targeted treatment, as trauma-focused therapies for PTSD may not fully resolve them. Imagery rehearsal therapy and the medication prazosin remain the most supported interventions, though results vary across studies. New consensus guidelines have produced Cognitive Behavioral Therapy for Nightmares, which combines rescripting, exposure, and sleep strategies. Emerging approaches such as digital self-management, brief coaching, lucid dreaming, and targeted memory reactivation show promise. Integrated treatments that sequence nightmare care with PTSD or insomnia therapies may improve outcomes, but evidence is mixed. The field needs standardized CBT-based approaches, consistent outcome measurement, and research on mechanisms and sequencing to optimize and expand access to nightmare treatment.